AIMS 2025: Emmanuel J Favaloro’s Haemostasis Tour Hits Finale
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn:
”Just completed my final session as the Australian Institute of Medical and Clinical Scientists (AIMS) 2025 Travelling Orator, in Adelaide for the South Australian (SA)/Northern Territory (NT) Branch. A well organised and well attended (pre-)Christmas meeting where I spoke on the topic of “Advances in Haemostasis”. This assignment has been an honour for me.
In total, 6 different venues, with 11 presentations, covering all states and territories in Australia (bar Queensland and the ACT). In total, around 500 attendees, both young and not so young.
Hope to be selected again before I hang up my haemostasis hat for good.”
Stay updated with Hemostasis Today.
-
Jun 21, 2026, 14:38Christina (Tina) P: Staying Safe on Anticoagulation Therapy in Antiphospholipid Syndrome
-
Jun 21, 2026, 14:32Moeen Hoseini: The Sex-Specific Associations Between Inflammatory Biomarkers and Vascular Events
-
Jun 21, 2026, 14:23Orton Lungu: Navigating High-Risk Pregnancy in Women Living With Sickle Cell Disease
-
Jun 21, 2026, 14:11Alexandre Kauskot: A Guide to Paris’s Best Riverside Spots for ISTH 2026 Attendees
-
Jun 21, 2026, 14:10Avidesh Panday: Data-Driven Stroke Care Transformation at EWMSC
-
Jun 21, 2026, 13:41Emmanuel J. Favaloro: Honored to Receive the ISLH Wallace H. Coulter Distinguished Lecture Award
-
Jun 21, 2026, 11:50Khalil Ahmad: The Incredible Journey of a Red Blood Cell – A Lifelong Mission of Oxygen Delivery
-
Jun 21, 2026, 08:44Patient Experience Sheds Light on Complexities of Antithrombotic Care in APS – APS Foundation of America
-
Jun 21, 2026, 08:04Phil Ambery: Next-Generation Endothelin Therapeutics Renew Interest in a Proven Pathway